The TORCH 5 IgM test detects IgM antibodies to Toxoplasma, Cytomegalovirus (CMV), Rubella, and Herpes Simplex Virus (HSV-1 & 2), aiding in the diagnosis of infections that can affect pregnancy
The TORCH 5 IgM test is a critical diagnostic tool used to detect IgM antibodies for five specific infections during pregnancy: Toxoplasmosis, Cytomegalovirus (CMV), Rubella, and Herpes Simplex Virus types 1 and 2 (HSV-1 & HSV-2). These infections can pose significant risks to both the mother and the developing fetus, making early detection essential.
The TORCH 5 IgM test is vital for identifying acute infections that may affect pregnant women and their unborn children. Elevated IgM antibody levels indicate recent infections, allowing healthcare providers to take necessary precautions and implement appropriate management strategies. Early diagnosis of these infections can help reduce the risk of complications such as congenital anomalies, neurological damage, and other serious health issues for the newborn.
Pregnant women or those planning to conceive should consider undergoing the TORCH 5 IgM test, especially if they exhibit symptoms associated with these infections or have had potential exposure. Additionally, healthcare providers may recommend this test for women with a history of recurrent miscarriages or previous children with congenital infections.
At Diagnopein, we offer the TORCH 5 IgM test with a commitment to quality and patient care. Our state-of-the-art technology ensures precise and reliable results, essential for guiding treatment decisions. We maintain high standards of cleanliness and hygiene in our testing environment, ensuring the safety of all patients. With our experienced staff, you can expect compassionate support and guidance throughout the testing process, making your experience as comfortable as possible.
The test detects IgM antibodies for Toxoplasmosis, Cytomegalovirus (CMV), Rubella, and Herpes Simplex Virus (HSV) types 1 and 2, indicating recent infections.
A blood sample is drawn, typically from a vein in your arm, and analyzed in a laboratory to determine the presence of IgM antibodies for the specified infections.
Positive IgM results suggest a recent infection, which may require further testing and evaluation by a healthcare provider to assess potential risks to the mother and fetus.
Generally, no specific preparations are required. However, it’s important to inform your healthcare provider about any symptoms or recent exposures you may have had.
